Chatillon, France

Bruno Giros



 

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 130(Granted Patents)


Location History:

  • Kremlin Bicetre, FR (1992 - 1994)
  • Chatillon, FR (1996 - 2013)

Company Filing History:


Years Active: 1992-2013

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bruno Giros

Introduction

Bruno Giros is a prominent inventor based in Chatillon, France, known for his significant contributions to the field of neuroscience. With a total of eight patents to his name, Giros has made remarkable strides in understanding and treating mood and anxiety disorders.

Latest Patents

Among his latest patents, one focuses on the treatment of mood and anxiety disorders. This invention relates to a selective inhibitor of Elk-1 or MSK-1 activation for use in the prevention and/or treatment of these disorders. Another notable patent involves the development of dopamine transporter knockout mice. This recombinant rodent comprises cells containing a pair of genomic dopamine transporter protein alleles, wherein at least one of the alleles is incapable of expressing endogenous dopamine transporter protein. The rodent may be a homozygote, where both alleles are incapable of expressing endogenous dopamine transporter protein, or a heterozygote, where one allele expresses endogenous dopamine transporter protein. The rodent is preferably a mouse.

Career Highlights

Throughout his career, Giros has worked with esteemed organizations such as Société Civile Bioprojet and Duke University. His work has significantly advanced the understanding of neurobiological mechanisms and potential therapeutic targets.

Collaborations

Giros has collaborated with notable colleagues, including Jean-Charles Schwartz and Jeanne-Marie Lecomte, further enhancing the impact of his research and innovations.

Conclusion

Bruno Giros stands out as a key figure in the field of neuroscience, with his innovative patents and collaborations contributing to advancements in the treatment of mood and anxiety disorders. His work continues to inspire future research and development in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…